Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Planning for the next influenza H1N1 season: a modelling study.

Identifieur interne : 003155 ( Main/Merge ); précédent : 003154; suivant : 003156

Planning for the next influenza H1N1 season: a modelling study.

Auteurs : Fabrice Carrat [France] ; Camille Pelat [France] ; Daniel Levy-Bruhl [France] ; Isabelle Bonmarin [France] ; Nathanael Lapidus [France]

Source :

RBID : Hal:inserm-00668438

Abstract

BACKGROUND: The level of herd immunity before and after the first 2009 pandemic season is not precisely known, and predicting the shape of the next pandemic H1N1 season is a difficult challenge. METHODS: This was a modelling study based on data on medical visits for influenza-like illness collected by the French General Practitioner Sentinel network, as well as pandemic H1N1 vaccination coverage rates, and an individual-centred model devoted to influenza. We estimated infection attack rates during the first 2009 pandemic H1N1 season in France, and the rates of pre- and post-exposure immunity. We then simulated various scenarios in which a pandemic influenza H1N1 virus would be reintroduced into a population with varying levels of protective cross-immunity, and considered the impact of extending influenza vaccination. RESULTS: During the first pandemic season in France, the proportion of infected persons was 18.1% overall, 38.3% among children, 14.8% among younger adults and 1.6% among the elderly. The rates of pre-exposure immunity required to fit data collected during the first pandemic season were 36% in younger adults and 85% in the elderly. We estimated that the rate of post-exposure immunity was 57.3% (95% Confidence Interval (95%CI) 49.6%-65.0%) overall, 44.6% (95%CI 35.5%-53.6%) in children, 53.8% (95%CI 44.5%-63.1%) in younger adults, and 87.4% (95%CI 82.0%-92.8%) in the elderly.The shape of a second season would depend on the degree of persistent protective cross-immunity to descendants of the 2009 H1N1 viruses. A cross-protection rate of 70% would imply that only a small proportion of the population would be affected. With a cross-protection rate of 50%, the second season would have a disease burden similar to the first, while vaccination of 50% of the entire population, in addition to the population vaccinated during the first pandemic season, would halve this burden. With a cross-protection rate of 30%, the second season could be more substantial, and vaccination would not provide a significant benefit. CONCLUSIONS: These model-based findings should help to prepare for a second pandemic season, and highlight the need for studies of the different components of immune protection.


Url:
DOI: 10.1186/1471-2334-10-301

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:inserm-00668438

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Planning for the next influenza H1N1 season: a modelling study.</title>
<author>
<name sortKey="Carrat, Fabrice" sort="Carrat, Fabrice" uniqKey="Carrat F" first="Fabrice" last="Carrat">Fabrice Carrat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Pelat, Camille" sort="Pelat, Camille" uniqKey="Pelat C" first="Camille" last="Pelat">Camille Pelat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Levy Bruhl, Daniel" sort="Levy Bruhl, Daniel" uniqKey="Levy Bruhl D" first="Daniel" last="Levy-Bruhl">Daniel Levy-Bruhl</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-9892" status="VALID">
<orgName>Département des maladies infectieuses</orgName>
<desc>
<address>
<addrLine>12, rue du vals D'Osne 94415 St Maurice Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300053" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300053" type="direct">
<org type="institution" xml:id="struct-300053" status="VALID">
<orgName>Institut de Veille Sanitaire </orgName>
<orgName type="acronym">INVS</orgName>
<desc>
<address>
<addrLine>12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bonmarin, Isabelle" sort="Bonmarin, Isabelle" uniqKey="Bonmarin I" first="Isabelle" last="Bonmarin">Isabelle Bonmarin</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-9892" status="VALID">
<orgName>Département des maladies infectieuses</orgName>
<desc>
<address>
<addrLine>12, rue du vals D'Osne 94415 St Maurice Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300053" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300053" type="direct">
<org type="institution" xml:id="struct-300053" status="VALID">
<orgName>Institut de Veille Sanitaire </orgName>
<orgName type="acronym">INVS</orgName>
<desc>
<address>
<addrLine>12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Lapidus, Nathanael" sort="Lapidus, Nathanael" uniqKey="Lapidus N" first="Nathanael" last="Lapidus">Nathanael Lapidus</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:inserm-00668438</idno>
<idno type="halId">inserm-00668438</idno>
<idno type="halUri">https://www.hal.inserm.fr/inserm-00668438</idno>
<idno type="url">https://www.hal.inserm.fr/inserm-00668438</idno>
<idno type="doi">10.1186/1471-2334-10-301</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Hal/Corpus">000467</idno>
<idno type="wicri:Area/Hal/Curation">000467</idno>
<idno type="wicri:Area/Hal/Checkpoint">000705</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000705</idno>
<idno type="wicri:doubleKey">1471-2334:2010:Carrat F:planning:for:the</idno>
<idno type="wicri:Area/Main/Merge">003155</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Planning for the next influenza H1N1 season: a modelling study.</title>
<author>
<name sortKey="Carrat, Fabrice" sort="Carrat, Fabrice" uniqKey="Carrat F" first="Fabrice" last="Carrat">Fabrice Carrat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Pelat, Camille" sort="Pelat, Camille" uniqKey="Pelat C" first="Camille" last="Pelat">Camille Pelat</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Levy Bruhl, Daniel" sort="Levy Bruhl, Daniel" uniqKey="Levy Bruhl D" first="Daniel" last="Levy-Bruhl">Daniel Levy-Bruhl</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-9892" status="VALID">
<orgName>Département des maladies infectieuses</orgName>
<desc>
<address>
<addrLine>12, rue du vals D'Osne 94415 St Maurice Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300053" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300053" type="direct">
<org type="institution" xml:id="struct-300053" status="VALID">
<orgName>Institut de Veille Sanitaire </orgName>
<orgName type="acronym">INVS</orgName>
<desc>
<address>
<addrLine>12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bonmarin, Isabelle" sort="Bonmarin, Isabelle" uniqKey="Bonmarin I" first="Isabelle" last="Bonmarin">Isabelle Bonmarin</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-9892" status="VALID">
<orgName>Département des maladies infectieuses</orgName>
<desc>
<address>
<addrLine>12, rue du vals D'Osne 94415 St Maurice Cedex</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-300053" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-300053" type="direct">
<org type="institution" xml:id="struct-300053" status="VALID">
<orgName>Institut de Veille Sanitaire </orgName>
<orgName type="acronym">INVS</orgName>
<desc>
<address>
<addrLine>12 rue du Val d'Osne, 94415 Saint Maurice Cedex, France</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Lapidus, Nathanael" sort="Lapidus, Nathanael" uniqKey="Lapidus N" first="Nathanael" last="Lapidus">Nathanael Lapidus</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-3065" status="OLD">
<orgName>Epidémiologie des maladies infectieuses et modélisation</orgName>
<orgName type="acronym">ESIM</orgName>
<desc>
<address>
<addrLine>Faculte de Médecine Saint-Antoine 27, Rue Chaligny 75571 Paris Cedex 12</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.u707.jussieu.fr</ref>
</desc>
<listRelation>
<relation active="#struct-93591" type="direct"></relation>
<relation name="U707" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-93591" type="direct">
<org type="institution" xml:id="struct-93591" status="OLD">
<orgName>Université Pierre et Marie Curie - Paris 6</orgName>
<orgName type="acronym">UPMC</orgName>
<date type="end">2017-12-31</date>
<desc>
<address>
<addrLine>4 place Jussieu - 75005 Paris</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.upmc.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="U707" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1186/1471-2334-10-301</idno>
<series>
<title level="j">BMC Infectious Diseases</title>
<idno type="ISSN">1471-2334</idno>
<imprint>
<date type="datePub">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>BACKGROUND: The level of herd immunity before and after the first 2009 pandemic season is not precisely known, and predicting the shape of the next pandemic H1N1 season is a difficult challenge. METHODS: This was a modelling study based on data on medical visits for influenza-like illness collected by the French General Practitioner Sentinel network, as well as pandemic H1N1 vaccination coverage rates, and an individual-centred model devoted to influenza. We estimated infection attack rates during the first 2009 pandemic H1N1 season in France, and the rates of pre- and post-exposure immunity. We then simulated various scenarios in which a pandemic influenza H1N1 virus would be reintroduced into a population with varying levels of protective cross-immunity, and considered the impact of extending influenza vaccination. RESULTS: During the first pandemic season in France, the proportion of infected persons was 18.1% overall, 38.3% among children, 14.8% among younger adults and 1.6% among the elderly. The rates of pre-exposure immunity required to fit data collected during the first pandemic season were 36% in younger adults and 85% in the elderly. We estimated that the rate of post-exposure immunity was 57.3% (95% Confidence Interval (95%CI) 49.6%-65.0%) overall, 44.6% (95%CI 35.5%-53.6%) in children, 53.8% (95%CI 44.5%-63.1%) in younger adults, and 87.4% (95%CI 82.0%-92.8%) in the elderly.The shape of a second season would depend on the degree of persistent protective cross-immunity to descendants of the 2009 H1N1 viruses. A cross-protection rate of 70% would imply that only a small proportion of the population would be affected. With a cross-protection rate of 50%, the second season would have a disease burden similar to the first, while vaccination of 50% of the entire population, in addition to the population vaccinated during the first pandemic season, would halve this burden. With a cross-protection rate of 30%, the second season could be more substantial, and vaccination would not provide a significant benefit. CONCLUSIONS: These model-based findings should help to prepare for a second pandemic season, and highlight the need for studies of the different components of immune protection.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003155 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003155 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Hal:inserm-00668438
   |texte=   Planning for the next influenza H1N1 season: a modelling study.
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021